CAR19TIF cells Clinical Trials

2 actively recruiting trials

Also known as: BCOR and ZC3H12 genes knock-out CD19 CAR T cells

Pipeline

Phase 1/2: 2

Top Sponsors

Chinese PLA General Hospital2

Indications

Cancer2
Acute Lymphocytic Leukemia1
B Cell Lymphoma1

Other2 trials

BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma

Phase 1/2

BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B-ALL

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.